Welcome Intec Pharma, currently conducting the Phase III ACCORDANCE study of the carbidopa/ levodopa “Accordion Pill.”
Moving Day has raised $50.2 million and brought more than 202,000 participants together.
Welcome Intec Pharma, currently conducting the Phase III ACCORDANCE study of the carbidopa/ levodopa “Accordion Pill.”
Moving Day has raised $50.2 million and brought more than 202,000 participants together.
Notifications
